ロード中...
An Overview of Hepatitis B Virus Surface Antigen Secretion Inhibitors
Current anti-hepatitis B virus (HBV) regimen do not meet ideal result due to emerging resistance strains, cytotoxicity, and unfavorable adverse effects. In chronic HBV infection, high rates of sub-viral particles (SVPs) bearing HBV surface antigen (HBsAg) is a major obstacle regarding to raise effec...
保存先:
| 出版年: | Front Microbiol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5895781/ https://ncbi.nlm.nih.gov/pubmed/29675010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2018.00662 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|